Diagnostic Value and Prognosis Significance of Cerebrospinal Fluid Examination by Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia

被引:0
作者
Xue, Lian [1 ]
Shang, Qianwen [1 ]
Lu, Aidong [1 ]
Zuo, Yingxi [1 ]
Ding, Mingming [1 ]
Zhang, Leping [1 ]
Jia, Yueping [1 ]
机构
[1] Peking Univ, Peoples Hosp, Pediat Dept, 11 Xizhimen South St, Beijing 100044, Peoples R China
关键词
flow cytometry; cerebrospinal fluid; central nervous system leukemia; acute lymphoblastic leukemia; children;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To explore the diagnostic value and the prognostic significance of cerebrospinal fluid (CSF) examination by flow cytometry (FC) in children with central nervous system leukemia (CNSL). Method: This is a retrospective observational study. We select 986 pediatric patients with newly diagnosed acute lymphoblastic leukemia from January 2012 to December 2018 as the research objects and analyze the sensitivity and specificity of different methods for diagnosing CNSL. The recurrence rate and survival rate of CNSL in different groups were compared. Results: Among the 986 cases, 31 cases (positive rate of 3.14%) were positive by FC, and the cytospin-based cytomorphology (CC) test was positive in 6 cases (positive rate of 0.61%). CC combined with FC might improve the diagnostic sensitivity (from 30% to 65%, (2) value was 5.143, P = .016). The 2-year event-free survival (EFS) of 31 FC + children was 59.5% +/- 9.2%, and that of 955 FC - children was 74.1% +/- 1.8% (P = .004). The 2-year overall survival (OS) of the 2 groups were 63.6% +/- 9.7% and 80.2% +/- 1.5%, respectively (P = .004). In order to exclude the influence of CNSL, we divided the patients into 3 groups: CNSL group and non-CNSL group with CSF FC + , FC - group. There was no significant difference in EFS between FC - group and non-CNSL group with FC + (2-year EFS were 74.1% +/- 1.8% and 68.7%+/- 9.8%, respectively, P = .142), and there was a significant difference in OS (2-year OS were 80.2% +/- 1.5% and 67.5% +/- 10.3%, respectively, P = .029). Conclusion: The test of FC combined with CC may improve the diagnostic sensitivity of CNSL. The EFS and OS of children with FC + are worse than those of children with FC -. However, for those patients with non-CNSL, but only FC + at the initial diagnosis, the EFS is not significantly affected by strengthening systemic chemotherapy and increasing the number of intrathecal injections.
引用
收藏
页数:6
相关论文
共 36 条
  • [21] Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic Nephropathy
    Marquardt, Andi
    Al-Dabet, Moh'd Mohanad
    Ghosh, Sanchita
    Kohli, Shrey
    Manoharan, Jayakumar
    ElWakiel, Ahmed
    Gadi, Ihsan
    Bock, Fabian
    Nazir, Sumra
    Wang, Hongjie
    Lindquist, Jonathan A.
    Nawroth, Peter Paul
    Madhusudhan, Thati
    Mertens, Peter R.
    Shahzad, Khurrum
    Isermann, Berend
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (11): : 3182 - 3189
  • [22] Mitochondrial fusion, fission, and mitochondrial toxicity
    Meyer, Joel N.
    Leuthner, Tess C.
    Luz, Anthony L.
    [J]. TOXICOLOGY, 2017, 391 : 42 - 53
  • [23] Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial
    Motzer, Robert J.
    Escudier, Bernard
    Oudard, Stephane
    Hutson, Thomas E.
    Porta, Camillo
    Bracarda, Sergio
    Gruenwald, Viktor
    Thompson, John A.
    Figlin, Robert A.
    Hollaender, Norbert
    Urbanowitz, Gladys
    Berg, William J.
    Kay, Andrea
    Lebwohl, David
    Ravaud, Alain
    [J]. LANCET, 2008, 372 (9637) : 449 - 456
  • [24] Drp1-dependent mitochondrial fission via MiD49/51 is essential for apoptotic cristae remodeling
    Otera, Hidenori
    Miyata, Non
    Kuge, Osamu
    Mihara, Katsuyoshi
    [J]. JOURNAL OF CELL BIOLOGY, 2016, 212 (05) : 531 - 544
  • [25] Prognostic relevance of the mTOR pathway in renal cell carcinoma - Implications for molecular patient selection for targeted therapy
    Pantuck, Allan J.
    Seligson, David B.
    Klatte, Tobias
    Yu, Hong
    Leppert, John T.
    Moore, Laurence
    O'Toole, Timothy
    Gibbons, Jay
    Belldegrun, Arie S.
    Figlin, Robert A.
    [J]. CANCER, 2007, 109 (11) : 2257 - 2267
  • [26] Regulation of autophagy by bile acids and in cholestasis - CholestoPHAGY or CholeSTOPagy
    Panzitt, Katrin
    Fickert, Peter
    Wagner, Martin
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2021, 1867 (02):
  • [27] Autolysosomal β-catenin degradation regulates Wnt-autophagy-p62 crosstalk
    Petherick, Katy J.
    Williams, Ann C.
    Lane, Jon D.
    Ordonez-Moran, Paloma
    Huelsken, Joerg
    Collard, Tracey J.
    Smartt, Helena J. M.
    Batson, Jennifer
    Malik, Karim
    Paraskeva, Chris
    Greenhough, Alexander
    [J]. EMBO JOURNAL, 2013, 32 (13) : 1903 - 1916
  • [28] Qu Y, 2016, ONCOTARGET, V7, P84775, DOI [10.18632/oncotarget.12476, 10.18632/oncotarget.12626]
  • [29] Activation of the mTOR signaling pathway in renal clear cell carcinoma
    Robb, Victoria A.
    Karbowniczek, Magdalena
    Klein-Szanto, Andres. J.
    Henskex, Elizabeth P.
    [J]. JOURNAL OF UROLOGY, 2007, 177 (01) : 346 - 352
  • [30] DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment
    Sarno, Federica
    Nebbioso, Angela
    Altucci, Lucia
    [J]. EPIGENETICS, 2020, 15 (05) : 439 - 453